M Cell-Targeted Mucosal Vaccine Strategies

被引:39
|
作者
Yamamoto, M. [1 ]
Pascual, D. W. [2 ]
Kiyono, H. [3 ]
机构
[1] Nihon Univ, Dept Oral Immunol, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan
[2] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA
[3] Univ Tokyo, Div Mucosal Immunol, Dept Microbiol & Immunol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan
来源
MUCOSAL VACCINES: MODERN CONCEPTS, STRATEGIES, AND CHALLENGES | 2012年 / 354卷
关键词
REGULATORY T-CELLS; FOLLICLE-ASSOCIATED EPITHELIUM; HEAT-LABILE ENTEROTOXIN; PATCH M-CELLS; PEYERS-PATCHES; ORAL TOLERANCE; ENHANCED MUCOSAL; IMMUNE-RESPONSE; CHOLERA-TOXIN; LYMPHOID FOLLICLES;
D O I
10.1007/82_2011_134
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune responses in the aerodigestive tract are characterized by production and transport of specific IgA antibodies across the epithelium to act as a first line of defense against pathogens in the external environment. To sample antigens on mucosal surfaces in the intestine and upper respiratory tract, the immune system relies on a close collaboration between specialized antigen-sampling epithelial M cells and lymphoid cells. Depending on various factors, local antigen presentation in the mucosal tissue leads to tolerance or initiation of an active immune response. Recently, molecules that could be used to target vaccine antigens to apical M cell surfaces have been identified. Here we review the M cell-targeted vaccine strategy, an approach that could be used to enhance uptake and efficacy of vaccines delivered in the nasal cavity or intestine.
引用
收藏
页码:39 / 52
页数:14
相关论文
共 50 条
  • [41] Delivery strategies to enhance mucosal vaccination
    Chadwick, Sandra
    Kriegel, Christina
    Amiji, Mansoor
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 427 - 440
  • [42] Vigilance or Subversion? Constitutive and Inducible M Cells in Mucosal Tissues
    Lo, David D.
    TRENDS IN IMMUNOLOGY, 2018, 39 (03) : 185 - 195
  • [43] Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting
    Kang, Sung Hun
    Hong, Seok Jin
    Lee, Yong-Kyu
    Cho, Sungpil
    POLYMERS, 2018, 10 (09):
  • [44] Mucosal Immunity and HIV-1 Infection: Applications for Mucosal AIDS Vaccine Development
    Belyakov, Igor M.
    Ahlers, Jeffrey D.
    MUCOSAL VACCINES: MODERN CONCEPTS, STRATEGIES, AND CHALLENGES, 2012, 354 : 157 - 179
  • [45] Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway
    Goitsuka, Ryo
    Chen, Chen-Io H.
    Benyon, Lesley
    Asano, Yusuke
    Kitamura, Daisuke
    Cooper, Max D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (38) : 15063 - 15068
  • [46] Advanced oral vaccine delivery strategies for improving the immunity q
    Zhang, Yuandong
    Li, Man
    Du, Guangsheng
    Chen, Xiaoyan
    Sun, Xun
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 177
  • [47] Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann, Jamie F. S.
    Acevedo, Reinaldo
    del Campo, Judith
    Perez, Oliver
    Ferrot, Valerie A.
    EXPERT REVIEW OF VACCINES, 2009, 8 (01) : 103 - 112
  • [48] EXPLORATION OF MUCOSAL IMMUNITY IN HUMANS - RELEVANCE TO VACCINE DEVELOPMENT
    CZERKINSKY, C
    HOLMGREN, J
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 : 37 - 44
  • [49] Recent progress in mucosal vaccine development: potential and limitations
    Lycke, Nils
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (08) : 592 - 605
  • [50] Oral paratuberculosis vaccine efficacy and mucosal immunity in cattle
    Eshraghisamani, Razieh
    Facciuolo, Antonio
    De Buck, Jeroen
    VACCINE, 2024, 42 (26)